These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
337 related articles for article (PubMed ID: 22028892)
1. The transcription factors Snail and Slug activate the transforming growth factor-beta signaling pathway in breast cancer. Dhasarathy A; Phadke D; Mav D; Shah RR; Wade PA PLoS One; 2011; 6(10):e26514. PubMed ID: 22028892 [TBL] [Abstract][Full Text] [Related]
2. RBM38 is involved in TGF-β-induced epithelial-to-mesenchymal transition by stabilising zonula occludens-1 mRNA in breast cancer. Wu J; Zhou XJ; Sun X; Xia TS; Li XX; Shi L; Zhu L; Zhou WB; Wei JF; Ding Q Br J Cancer; 2017 Aug; 117(5):675-684. PubMed ID: 28683467 [TBL] [Abstract][Full Text] [Related]
3. The transcription factor snail mediates epithelial to mesenchymal transitions by repression of estrogen receptor-alpha. Dhasarathy A; Kajita M; Wade PA Mol Endocrinol; 2007 Dec; 21(12):2907-18. PubMed ID: 17761946 [TBL] [Abstract][Full Text] [Related]
4. Curcumin and emodin down-regulate TGF-β signaling pathway in human cervical cancer cells. Thacker PC; Karunagaran D PLoS One; 2015; 10(3):e0120045. PubMed ID: 25786122 [TBL] [Abstract][Full Text] [Related]
5. The Src family kinase inhibitors PP2 and PP1 block TGF-beta1-mediated cellular responses by direct and differential inhibition of type I and type II TGF-beta receptors. Ungefroren H; Sebens S; Groth S; Gieseler F; Fändrich F Curr Cancer Drug Targets; 2011 May; 11(4):524-35. PubMed ID: 21395548 [TBL] [Abstract][Full Text] [Related]
6. Heterodimer formation by Oct4 and Smad3 differentially regulates epithelial-to-mesenchymal transition-associated factors in breast cancer progression. Mandal G; Biswas S; Roy Chowdhury S; Chatterjee A; Purohit S; Khamaru P; Chakraborty S; Mandal PK; Gupta A; de la Mare JA; Edkins AL; Bhattacharyya A Biochim Biophys Acta Mol Basis Dis; 2018 Jun; 1864(6 Pt A):2053-2066. PubMed ID: 29526821 [TBL] [Abstract][Full Text] [Related]
7. Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells. Zhang J; Thorikay M; van der Zon G; van Dinther M; Ten Dijke P J Vis Exp; 2020 Oct; (164):. PubMed ID: 33191940 [TBL] [Abstract][Full Text] [Related]
8. Interferon consensus sequence-binding protein (ICSBP) promotes epithelial-to-mesenchymal transition (EMT)-like phenomena, cell-motility, and invasion via TGF-β signaling in U2OS cells. Sung JY; Park SY; Kim JH; Kang HG; Yoon JH; Na YS; Kim YN; Park BK Cell Death Dis; 2014 May; 5(5):e1224. PubMed ID: 24832596 [TBL] [Abstract][Full Text] [Related]
9. IKK(α) controls canonical TGF(ß)-SMAD signaling to regulate genes expressing SNAIL and SLUG during EMT in panc1 cells. Brandl M; Seidler B; Haller F; Adamski J; Schmid RM; Saur D; Schneider G J Cell Sci; 2010 Dec; 123(Pt 24):4231-9. PubMed ID: 21081648 [TBL] [Abstract][Full Text] [Related]
10. Lack of transforming growth factor-β signaling promotes collective cancer cell invasion through tumor-stromal crosstalk. Matise LA; Palmer TD; Ashby WJ; Nashabi A; Chytil A; Aakre M; Pickup MW; Gorska AE; Zijlstra A; Moses HL Breast Cancer Res; 2012 Jul; 14(4):R98. PubMed ID: 22748014 [TBL] [Abstract][Full Text] [Related]
11. Notch1 signaling regulates the epithelial-mesenchymal transition and invasion of breast cancer in a Slug-dependent manner. Shao S; Zhao X; Zhang X; Luo M; Zuo X; Huang S; Wang Y; Gu S; Zhao X Mol Cancer; 2015 Feb; 14(1):28. PubMed ID: 25645291 [TBL] [Abstract][Full Text] [Related]
12. Fucoidan induces changes in the epithelial to mesenchymal transition and decreases metastasis by enhancing ubiquitin-dependent TGFβ receptor degradation in breast cancer. Hsu HY; Lin TY; Hwang PA; Tseng LM; Chen RH; Tsao SM; Hsu J Carcinogenesis; 2013 Apr; 34(4):874-84. PubMed ID: 23275155 [TBL] [Abstract][Full Text] [Related]
13. Elevated TGF-β1 and -β2 expression accelerates the epithelial to mesenchymal transition in triple-negative breast cancer cells. Kim S; Lee J; Jeon M; Nam SJ; Lee JE Cytokine; 2015 Sep; 75(1):151-8. PubMed ID: 26088755 [TBL] [Abstract][Full Text] [Related]
14. Molecular mechanism of miR-153 inhibiting migration, invasion and epithelial-mesenchymal transition of breast cancer by regulating transforming growth factor beta (TGF-β) signaling pathway. Wang J; Liang S; Duan X J Cell Biochem; 2019 Jun; 120(6):9539-9546. PubMed ID: 30525231 [TBL] [Abstract][Full Text] [Related]
15. Foxf2 plays a dual role during transforming growth factor beta-induced epithelial to mesenchymal transition by promoting apoptosis yet enabling cell junction dissolution and migration. Meyer-Schaller N; Heck C; Tiede S; Yilmaz M; Christofori G Breast Cancer Res; 2018 Oct; 20(1):118. PubMed ID: 30285803 [TBL] [Abstract][Full Text] [Related]
16. Long non-coding RNAs AC026904.1 and UCA1: a "one-two punch" for TGF-β-induced SNAI2 activation and epithelial-mesenchymal transition in breast cancer. Li GY; Wang W; Sun JY; Xin B; Zhang X; Wang T; Zhang QF; Yao LB; Han H; Fan DM; Yang AG; Jia LT; Wang L Theranostics; 2018; 8(10):2846-2861. PubMed ID: 29774079 [TBL] [Abstract][Full Text] [Related]
17. Distinct roles of transforming growth factor-β signaling and transforming growth factor-β receptor inhibitor SB431542 in the regulation of p21 expression. Koo BH; Kim Y; Je Cho Y; Kim DS Eur J Pharmacol; 2015 Oct; 764():413-423. PubMed ID: 26187313 [TBL] [Abstract][Full Text] [Related]
18. A novel molecular pathway for Snail-dependent, SPARC-mediated invasion in non-small cell lung cancer pathogenesis. Grant JL; Fishbein MC; Hong LS; Krysan K; Minna JD; Shay JW; Walser TC; Dubinett SM Cancer Prev Res (Phila); 2014 Jan; 7(1):150-60. PubMed ID: 24253315 [TBL] [Abstract][Full Text] [Related]
19. Resveratrol suppresses epithelial-to-mesenchymal transition in colorectal cancer through TGF-β1/Smads signaling pathway mediated Snail/E-cadherin expression. Ji Q; Liu X; Han Z; Zhou L; Sui H; Yan L; Jiang H; Ren J; Cai J; Li Q BMC Cancer; 2015 Mar; 15():97. PubMed ID: 25884904 [TBL] [Abstract][Full Text] [Related]
20. EW-7203, a novel small molecule inhibitor of transforming growth factor-β (TGF-β) type I receptor/activin receptor-like kinase-5, blocks TGF-β1-mediated epithelial-to-mesenchymal transition in mammary epithelial cells. Park CY; Kim DK; Sheen YY Cancer Sci; 2011 Oct; 102(10):1889-96. PubMed ID: 21707864 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]